Patients with pneumonia can be a diagnostic problem for physicians. Present methods for determining the pathogen in this setting may be inaccurate, making selection of an appropriate antibiotic difficult. For example, the sputum examination and culture may be imprecise, particularly if improper techniques are used, and reliance on these methods can lead to an incorrect initial diagnosis (2, 10, 11) . Even pneumococcal pneumonia, the most common bacterial pneumonia, may be misdiagnosed. Pneumonia due to other serious penicillin-resistant pathogens such as Staphylococcus aureus and Haemophilus influenzae may be initially mistaken for pneumococcal pneumonia and inappropriately treated.
Because of the difficulty in reaching an accurate diagnosis before culture results are available, it might be appropriate to initially treat a patient presumed to have pneumococcal pneumonia with an agent effective not only against pneumococci, but also against the other common pathogens, particularly if the patient is seriously ill. Cefamandole, a new cephalosporin antibiotic, provides such broad-spectrum coverage, with activity against Streptococcus pneumoniae, S. aureus, and many gram-negative organisms including H. influenzae and Klebsiella pneumoniae (7, 9) . However, cefamandole would not be an acceptable altemative to penicillin if it caused more adverse effects, colonization, or superinfection, or was less effective in eradicating the pneumococci. To investigate these issues, we conducted a randomized, prospective, doubleblind comparison of cefamandole and penicillin in the treatment of patients with presumed or proven pneumococcal pneumonia.
MATERIALS AND METHODS One hundred adult patients with community-acquired pneumonia, who had been hospitalized on the medical service of the Johns Hopkins Hospital, Baltimore, were admitted to the study. A 
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The pathogen causing illness in each patient was determined by the results of blood and sputum cultures, as well as review of the sputum Gram stain in a blind fashion by the investigators and by an independent clinical microbiologist. The sputum stain was considered diagnostic of pneumococcal pneumonia if: (i) there were less than 10 squamous cells per lowpower field; (ii) polymorphonuclear leukocytes or alveolar macrophages were present; and (iii) the predominant organisms present were gram-positive diplococci, without remarkable numbers of other organisms.
The diagnosis of pneumococcal pneumonia was based on the presence of an infiltrate on chest X-ray in the setting of an acute respiratory illness and the presence of either (i) a moderate to heavy growth of S. pneumoniae from sputum cultures, (ii) a sputum smear that fulfilled our criteria for a diagnostic Gram stain or (iii) growth of S. pneumoniae from blood or transtracheal aspirate cultures.
RESULTS
Of the 100 patients entered into the study, 96 had radiographic evidence of pneumonia. Of these, 49 (51%) had pneumonia attributed to S. pneumoniae alone, by our criteria. Three patients had pneumonia attributed to S. pneumoniae plus another pathogen, and 13 patients had pneumonia attributed to various nonpneumococcal, gram-positive and/or gram-negative organisms. In 31 patients, no definite pathogen was demonstrated.
Of the 49 patients with pneumonia due solely to S. pneumoniae, 24 were treated with cefamandole and 25 were treated with penicillin. Demographic data for these patients are included in Table 1 . There was no significant difference due to the age, sex, initial WBC count, initial temperature, or underlying diseases of the patients, or to the duration of therapy.
Five of the patients (10.2%) with pneumococcal pneumonia had positive blood cultures and 36 (73.5%) had positive sputum cultures (Fig. 1) .
Fifteen of these cultures were obtained by transtracheal aspiration. Sputum stains were available in 47 cases, and 37 (78.7%) had a diagnostic sputum stain. Of the 36 patients with positive sputum cultures, Gram stains were available for 34, and 25 (73.5%) were diagnostic. Of the 37 patients with sputum stains thought to be diagnostic of pneumococcal pneumonia, 25 (67.6%) had positive sputum cultures for pneumococcus, 2 were positive for nonpneumococcal streptococci, 1 was positive for K. pneumoniae, and 9 grew only normal respiratory flora. The minimal inhibitory concentration of cefamandole for pneumococci was O0.5 ,ug/ml, except for one organism for which it was 1 Ag/ml. Penicillin susceptibility was tested in 21 pneumococci. (Fig. 2) . Follow-up appointments were made for all patients who completed the protocol, but only 17 of the group treated with cefamandole (70.8%) and 14 treated with penicillin (56%) returned. Of those who were seen at follow-up, only one patient in each group was not cured. In the cefamandole group, one patient was judged a failure because his chest radiograph did not improve after treatment, although he became asymptomatic and afebrile. Within 1 month, the cause was found to be lung carcinoma. The failure on penicillin therapy had an excellent initial response and was afebrile for 5 days. On day 7, however, the fever spiked, and blood cultures were positive for Enterobacter cloacae. Her chest radiograph was much improved compared with that at the time of admission, and no potential source for this infection except her indwelling intravenous catheter could be found. There was no significant differ- ence in the course of those patients with pneumococcal pneumonia treated with either antibiotic. Twenty of 24 patients (83.3%) treated with cefamandole and 20 of 25 patients (80%) treated with penicillin were afebrile by the second full day of therapy (Fig. 2) . A decrease in WBC count of at least 15% or to normal was achieved in 21 of 23 patients (91.3%) in both groups by day 3. After the clinical data were reviewed, 13 patients were believed to have bacterial pneumonia due to nonpneumococcal pathogens (Table 2) . In each case, the initial sputum Gram stain was interpreted by the physician of the patient as indicating infection with S. pneumoniae. Three types of errors were made by the physicians in interpreting these stains: (i) interpretation of poor-quality stains, (ii) misidentification of the species of gram-positive cocci, and (iii) failure to recognize the presence of gram-negative organisms on the slides. These patients were switched to other antibiotics after it became known that their infection was not pneumococcal. Because of the small numbers of patients, varied duration of therapy, and variety of pathogens, we can make no statement regarding efficacy of either agent in this group. The Of the 93 patients treated for 3 days or more and evaluated for toxicity, 47 were treated with cefamandole and 46 were treated with penicillin. No significant difference existed between those who received cefamandole and those who received penicillin, with regard to mean age (52 versus 45 years, respectively), duration of therapy (6.6 versus 6.4, respectively), or underlying diseases (alcoholism and chronic obstructive lung disease). More of the patients receiving cefamandole were male (79% cefamandole versus 60% penicillin).
One adverse effect of cefamandole therapy was that one patient developed a positive direct Coombs test. A mild hemolytic process may have been associated with this abnormality, but absolute evidence is lacking. Thrombocytosis, elevated liver function tests, and a fall in hematocrit levels occurred after both kinds of therapy (Table 3 ). About 5% of the patients in both groups developed an unexplained increase in serum creatinine; the differences between penicillin-and cefamandole-treated patients were not statistically significant. Eosinophilia occurred more often in patients treated with penicillin than in those treated with cefamandole, although no other evidence of hypersensitivity developed in any of these patients.
Colonization occurred in 13 (8) . In our series, interpretation of poor slides led to the improper diagnosis of streptococcal, mycoplasma, staphylococcal, and klebsiella pneumonia, emphasizing the importance of using strict criteria when interpreting Gram stains. We reviewed our slides by using established criteria and had our slides reviewed blindly by an independent microbiologist. In addition, our cases were evaluated in a double-blind manner, thus eliminating the possibility of bias.
Both cephaloridine and lincomycin have been compared with penicillin G in the treatment of pneumococcal pneumonia. Tempest and Austrian compared 1 g of cephaloridine per day given intramuscularly (i.m.) with 600,000 U of penicillin per day given i.m. and found no difference in efficacy (12) . Anderson et al. compared 1.2 g of lincomycin per day given i.m. with 600,000 U of penicillin G per day given i.m. and found similar results (1). Cherubin et al. compared 1.2 g of lincomycin per day i.m., 2 g of cephaloridine per day i.m., and 1.2 x 106 U of procaine penicillin per day i.m. and found that these regimens were equally effective (4). Our study differs from these reports in three ways: (i) we evaluated an antibiotic, cefamandole, that is effective against all of the organisms that commonly cause bacterial pneumonia, including H. influenzae; (ii) we evaluated the incidence of colonization and superinfection; and (iii) our study was double-blind, thus eliminating the possibility of bias. We have found that there is no statistically significant difference between 4 g of cefamandole per day and 2.4 x 106 U of penicillin G per day, and, due to the size of our study, we could exclude differences of 25% or greater.
In contrast to the other comparative trials, we evaluated the incidence of colonization and superinfection. Louria and Brayton (5) and Tillotson and Finland (14) have reported that doses of penicillin G greater than 2.4 x 106 and 3.0 x 106 U/day result in a higher incidence of colonization and superinfection. Tillotson and Finland (14) have suggested that broad-spectrum antibiotics are also associated with an increased incidence of these adverse effects. We found a low incidence of colonization and superinfection by using a dose of 2.4 
